Start a live chat
1-800-870-4800
The Longevity Code · Daily Foundation
Fourteen days,
more or less fixed.
The second half of the cycle keeps a length of its own. It is set by a temporary structure with a limited lifespan, and almost everything that distinguishes these days follows from that.
In brief
The luteal phase is the part of the menstrual cycle that runs from ovulation to the start of the next period. It most often lasts between twelve and fourteen days, and unlike the first half of the cycle it holds a fairly consistent length from one month to the next.
It takes its name from the corpus luteum, the temporary structure left behind in the ovary after an egg is released. That structure produces progesterone, has a limited lifespan of its own, and when it regresses the next period begins.
I
A structure with a lifespan.
When the dominant follicle releases its egg, it does not simply disappear. What remains collapses and reorganises into the corpus luteum, a temporary endocrine structure that exists for a fortnight and then regresses. The luteal phase is named after it, and is defined by what it produces.
That product is progesterone. Where the first half of the cycle is led by rising estradiol from a growing follicle, the second half is led by progesterone from a structure that is already finished growing. The two halves are driven by different sources on different schedules, which is why they behave so differently.
In the uterus, progesterone turns the lining that thickened across the follicular phase into a secretory one. That is why the uterine name for this stretch is the secretory phase, and why some clinical descriptions use that word instead.
If no pregnancy occurs, the corpus luteum regresses on its own schedule, progesterone and estradiol both fall, and the next period begins. The cycle returns to day one. The full sequence across the month is set out in the guide to the four phases.
The second half
The luteal phase, at a glance.
Commonly cited ranges for adult cycles. Individual cycles vary, though this phase varies considerably less than the first half does.
| Feature | What it is |
|---|---|
| Begins | At ovulation, when the dominant follicle releases its egg. |
| Ends | On the first day of the next period, which is day one of the following cycle. |
| Typical length | Most often 12 to 14 days, and considerably more consistent than the follicular phase. |
| Dominant hormone | Progesterone from the corpus luteum, with a secondary rise in estradiol. |
| Uterine name | The secretory phase, describing what the endometrium becomes. |
| What ends it | Regression of the corpus luteum, and the fall in progesterone and estradiol that follows. |
The corpus luteum has a lifespan of roughly a fortnight, and the phase lasts as long as it does.
II
The half that does not move much.
Cycle length differs between people and between months in the same person, and almost all of that difference sits in the first half. A twenty-four day cycle and a thirty-four day cycle usually differ in how long it took to reach ovulation, not in what happened afterwards.
The reason is structural. The follicular phase runs until a follicle matures, which is a variable process shaped by many inputs. The luteal phase runs until a structure with a limited lifespan regresses, which is a far more fixed one. The corpus luteum does not wait to see how long the first half took.
This is the fact that makes the luteal phase useful as a reference point. In fertility research, counting backwards from the start of a period gives a more reliable estimate of when ovulation occurred than counting forwards from the previous one, precisely because the second interval is the steadier of the two.
It is also why day-by-day charts built on a textbook twenty-eight day cycle mislead. They place ovulation at a fixed day fourteen. In practice ovulation moves with the length of the first half, and the luteal phase stays roughly where it is relative to the next period.
III
What changes across these days.
Progesterone raises basal body temperature slightly, by a few tenths of a degree, and holds it there for the duration of the phase. That small step is the signal fertility tracking methods look for, and it falls again as the phase ends. It is a marker of what has already happened rather than a prediction of what is coming.
Progesterone is also metabolised into allopregnanolone, a neurosteroid that acts on the same receptor system as the body's main inhibitory neurotransmitter. The research literature on premenstrual disorders pays close attention to this pathway, and to sensitivity to it, rather than to the absolute level of any hormone.
That distinction matters. One review of the literature notes that premenstrual disorders do not appear to be explained by a hormone imbalance, but by how the brain responds to the ordinary fluctuations of a normal cycle. Symptoms reported in the late luteal days are common: one review of female athletes cited a figure of around eighty-one percent for premenstrual symptom reporting in the late luteal phase.
These are descriptions of what researchers observe across populations. Studies referenced here were conducted independently and did not involve any specific Codeage product.
The steadier half
A fortnight that keeps its own time.
The first half of the cycle varies. The second half runs on the lifespan of a structure, and that lifespan is far more consistent.
Across the fortnight
Four things that define the phase.
The hormone, the span it runs for, and the nutrients the research literature returns to.
The hormone
One broad rise
Progesterone climbs after ovulation, holds through the middle of the phase, and falls as the corpus luteum regresses.
The span
Twelve to fourteen
A counted, finite stretch. The corpus luteum regresses on roughly this schedule regardless of how long the first half ran.
The mineral
Magnesium, and its forms
The mineral most often examined in premenstrual research, usually alongside vitamin B6 rather than on its own.
The foods
Where it occurs
Seeds, nuts, legumes, leafy greens and cocoa are among the more concentrated dietary sources of magnesium.
IV
What the literature keeps returning to.
A small group of nutrients appears repeatedly in research on the late luteal days. A 2023 review in Frontiers in Nutrition noted that hypotheses about premenstrual symptoms have long included dietary shortfalls, with vitamin B6, magnesium and calcium named most often, and with a separate body of work examining vitamin D.
The most cited single trial is small and old. A randomised crossover study of forty-four British women, described in a 2025 systematic review in Nutrition Reviews, gave a daily combination of 200 mg of magnesium and 50 mg of vitamin B6 for one month, and researchers reported a significant decrease in anxiety-related symptom scores compared with either nutrient alone or with placebo.
That same review is careful about what follows from it. It concludes that overall evidence for combined nutrient supplements in this context is limited, and that the optimal dose and composition are not established. Other reviews note that superiority over placebo has not been consistently demonstrated, and that better quality data is needed.
This is the honest state of the subject: a plausible and repeatedly examined association, with a literature that has not settled. Studies referenced here were conducted independently and did not involve any specific Codeage product.
The first half of the cycle answers to a follicle.
The second answers to a structure
that already knows how long it has.
V
A note on vitamin B6.
Vitamin B6 is worth reading about carefully rather than casually, because it is one of the few water-soluble vitamins with a well documented upper limit. Guidance from the Royal College of Obstetricians and Gynaecologists mentions B6 while cautioning that the doses used in studies are high enough to carry a risk of peripheral neuropathy.
The United Kingdom Department of Health restricts the daily supplemental dose to 10 mg for that reason, a figure well below the amounts used in most of the published trials. Anyone reading a trial dose and a product panel side by side should notice the gap rather than assume they describe the same thing.
The form is stated on the panel too. B6 appears either as pyridoxine hydrochloride or as pyridoxal-5-phosphate, sometimes shortened to P-5-P, which is the form the body uses directly. Which one a formula uses is a formulation decision and it is declared.
None of that is a reason to avoid the vitamin. It is a reason to read the number, and to treat any amount well above ordinary dietary intake as a conversation with a qualified healthcare professional rather than a self-directed experiment.
The vocabulary
Six terms worth knowing precisely.
The luteal phase has its own small vocabulary, and most confusion comes from these six words being used loosely.
Corpus luteum
The temporary endocrine structure formed from the follicle after it releases its egg. It produces progesterone and has a lifespan of roughly a fortnight.
Progesterone
The hormone that leads the second half of the cycle. It turns the thickened endometrium into a secretory lining and raises basal body temperature slightly.
Secretory phase
The uterine name for the same stretch of days, describing what the lining becomes. The luteal phase is the ovarian name for it.
Allopregnanolone
A neurosteroid the body makes from progesterone. Research on premenstrual disorders examines sensitivity to it rather than the amount present.
Basal body temperature
Resting temperature on waking. It steps up slightly after ovulation under progesterone and falls again as the phase ends.
Late luteal
The final days before a period, when progesterone and estradiol are falling. The stretch most research on premenstrual symptoms focuses on.
The close of the month
The end of a cycle, not the end of anything.
When the corpus luteum regresses, the sequence returns to its beginning. The phase closes a month and opens the next one.
VI
Where this fits.
The nutrients described here sit inside Daily Foundation, the first pillar of The Longevity Code, the pillar concerned with the foundational minerals and vitamins a daily routine is built on. A pillar is a location within a framework. It describes a category, not an outcome for any individual reader.
Magnesium belongs there for the same reason iron does. It is not a compound anyone discovers in midlife. It is a foundational mineral with a published reference intake, present across a wide range of ordinary foods, and studied in many contexts of which this is one.
Formulations across the pillars are built around ingredients researched in the contexts described here. Any research referenced was conducted independently and did not involve any specific Codeage product.
Questions
What people ask most.
What is the luteal phase?
How long is the luteal phase?
Which day does the luteal phase start?
What hormone is dominant in the luteal phase?
Why does body temperature rise after ovulation?
What is the difference between the luteal phase and the secretory phase?
Which nutrients are studied in relation to the late luteal days?
Is a short luteal phase something to ask about?
Twelve to fourteen days.
A fortnight that keeps its own time.
What the second half of the cycle is, and what the research describes about it.
Codeage · Daily Foundation · Pillar 01
Liposomal Magnesium Glycinate Capsules.
Bioavailable magnesium.
Magnesium supplied as bisglycinate chelate alongside magnesium oxide, with BioPerine black pepper fruit extract, in the Codeage Helix liposomal delivery format.
- Mineral forms Magnesium bisglycinate chelate and oxide
- Also includes BioPerine black pepper fruit extract
- Delivery Codeage Helix liposomal format
- Pillar 01 Daily Foundation
- Label Non-GMO, formulated without dairy, soy, or gluten
Continue reading
Further reading from the Codeage library.
This article is provided for educational and informational purposes only and has been reviewed against FDA and FTC guidelines to ensure it does not make any health, disease, or treatment claim. Phase durations are described as commonly cited ranges observed across populations rather than fixed values for any individual. Research findings described are reported outcomes from independent studies that did not involve any specific Codeage product, and reviews of that literature describe the evidence as limited. This article is not a diagnostic guide and is not a substitute for advice from a qualified healthcare professional. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
